SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-015494
Filing Date
2021-11-10
Accepted
2021-11-10 16:14:40
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K htbx-20211110x8k.htm   iXBRL 8-K 35671
2 EX-99.1 htbx-20211110xex99d1.htm EX-99.1 230372
3 GRAPHIC htbx-20211110xex99d1001.jpg GRAPHIC 4005
  Complete submission text file 0001558370-21-015494.txt   401721

Data Files

Seq Description Document Type Size
4 EX-101.SCH htbx-20211110.xsd EX-101.SCH 3033
5 EX-101.LAB htbx-20211110_lab.xml EX-101.LAB 15412
6 EX-101.PRE htbx-20211110_pre.xml EX-101.PRE 9806
7 EXTRACTED XBRL INSTANCE DOCUMENT htbx-20211110x8k_htm.xml XML 4726
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 211396771
SIC: 2834 Pharmaceutical Preparations